RT @rasharezk_: We are hiring!!🚀🚀 Great experience working with a very cool microfluidic tech #ForCell and gaining expertise in blood stem…

@aloktayi Very intriguing! What was the name of the company?

@DrSynbio It’s very encouraging to see how many new non-viral technologies are currently appearing. In addition to unlocking new tropism, the ability to repeat dose can facilitate new therapeutic approaches. Exciting times!

RT @scienceadvocacy: Postdoc @MJassinskaja and @BBSRCWhiteRose PhD student Monika Gonka pull together a top rate summary of the tools that…

@AlexHarding7 That’s a very concerning statistic, especially for such serious diseases. It also raises the question how this might impact reimbursement schemes for new curative approaches, e.g. gene therapies?

RT @scienceadvocacy: Share as widely as possible please. This programme has been a real game changer in the Department for widening acce…

@shelbynewsad Check out the work by @sendabioscience

@shelbynewsad Very interesting article! Characterising nanoparticles across other species/systems will likely uncover new mechanisms and tropism for previously hard-to-reach cell types - could go beyond gene and cell therapies

RT @STRMbio: There is a lot of excitement brewing at Looking forward to seeing you at J.P. Morgan. #JPM23 https:…

RT @IdoAmitLab: Congratulations Ali @erturklab, Matthias @labs_mann, Fabian @fabian_theis and teams for this tour de force study, brilliant…

@RuxandraTeslo @StankovicStasa have you come across this work?

@ForbionLifeSci @marcturg @Tim_Lohoff Congratulations Tim! Well deserved

@Biotech2k1 What do you think about the selection of indications? Particularly for NTLA-2001 and 2002?

RT @shelbynewsad: *Looking for a part-time researcher to join the @CompoundVC squad* 🚀 The researcher will be working directly with me on…

@andrewpannu Lovely summary and captures many key events - thank you for sharing!

@LaurinHahn This is great news! Just a quick question - what is the anticipated km driving range generated with the daily energy earnings? Thank you

RT @scienceadvocacy: Good things come in bunches! Well done to @Bode_Dan and @jimseeche for this @emboreports paper that identifies and ch…

@scienceadvocacy @SCICambridge @YBRI_UoY @JonathanThon @Nina_CabezasW Thank you very much for all your support and mentorship on this journey!

RT @lpachter: It's time to stop making t-SNE & UMAP plots. In a new preprint w/ Tara Chari we show that while they display some correlation…